Morgan Stanley
WGSWW

Morgan Stanley’s GeneDx Holdings Warrant WGSWW Stock Holding History

Morgan Stanley’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,750
Closed -$49 – 7710
2023
Q2 		$49 Buy
4,750
+4,684
+7,097% +$83 ﹤0.01% 7538
2023
Q1 		$1 Hold
66
– – ﹤0.01% 7703
2022
Q4 		$1 Hold
66
– – ﹤0.01% 7875
2022
Q3 		$0 Hold
66
– – ﹤0.01% 7891
2022
Q2 		$0 Hold
66
– – ﹤0.01% 7990
2022
Q1 		$0 Hold
66
– – ﹤0.01% 8132
2021
Q4 		$0 Sell
66
-400
-86% -$787 ﹤0.01% 8121
2021
Q3 		$1K Buy
466
+66
+17% +$217 ﹤0.01% 7810
2021
Q2 		$2K Hold
400
– – ﹤0.01% 7543
2021
Q1 		$2K Buy
+400
New +$2.22K ﹤0.01% 7286

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Morgan Stanley's WGSWW Position: Q3 2023 in Review

Morgan Stanley sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2023, closing a stake of 4,750 shares — an estimated $49 sold.

Morgan Stanley first reported a position in WGSWW in Q1 2021 and held it in 10 quarters. The position peaked at $2K in Q2 2021. 22 funds tracked by Wall St. Rank hold WGSWW as of Q3 2023.

  • Morgan Stanley reported no remaining GeneDx Holdings Warrant position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 4,750 GeneDx Holdings Warrant shares in Q3 2023, an estimated $49.
  • Morgan Stanley first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 10 quarters.
  • Morgan Stanley's GeneDx Holdings Warrant position peaked at $2K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.